# Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery

> **NCT00770705** · PHASE2 · WITHDRAWN · sponsor: **Vanderbilt University**

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DRUG:** Phenoxybenzamine
- **OTHER:** Standard surgical approach

## Key facts

- **NCT ID:** NCT00770705
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-10
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** poor enrollment
- **Last updated:** 2017-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770705, "Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00770705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*